Separating the Hype from the Hyperbole Surrounding FDORA’s Alternatives to Animal Testing under the FD&C Act
FDA Law Blog: Drug Discovery
FEBRUARY 2, 2023
The definition goes on to list potential options for such tests: cell-based assays, organ chips and microphysiological systems, computer modeling, other nonhuman or human biology-based test methods such as bioprinting, as well as animal tests. For more on FDORA’s other provisions, see HPM’s complete summary here ).
64 
Let's personalize your content